"We cannot continue to wait for other people to do the research," says Hsueh. "Or wait for intellectual property protections on new drugs to expire so we can produce them cheaply."
「我們不能老是在等別人研發、等新藥智財保護的專利期過後，再以低廉的代價，撿拾別人售出的學名藥來生產，」薛瑞元說。